By expenditures
| Name | Title | Type |
|---|---|---|
| Holly Paulson | BUSINESS MANAGER | Auditee |
| Derek Flanagan | Partner | Auditee |
| Brian Opsahl | Principal | Auditee |
| Tracee Bruggeman | SHAREHOLDER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 325307 | 2024 | 2024-10-21 | Brady Martz & Associates PC | $902,317 |
| 736 | 2023 | 2023-10-17 | Brady Martz & Associates PC | $1.23M |
| 55461 | 2022 | 2022-11-01 | Eide Bailly LLP | $1.61M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 325307 | 2024 | 2024-10-21 | 1079699 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 1079698 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 1079697 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 1079696 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 1079695 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 1079694 | 2024-003 | Significant Deficiency | - | AB |
| 325307 | 2024 | 2024-10-21 | 1079693 | 2024-003 | Significant Deficiency | - | AB |
| 325307 | 2024 | 2024-10-21 | 503257 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 503256 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 503255 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 503254 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 503253 | 2024-004 | Significant Deficiency | - | L |
| 325307 | 2024 | 2024-10-21 | 503252 | 2024-003 | Significant Deficiency | - | AB |
| 325307 | 2024 | 2024-10-21 | 503251 | 2024-003 | Significant Deficiency | - | AB |
| 736 | 2023 | 2023-10-17 | 576804 | 2023-003 | Significant Deficiency | - | AB |
| 736 | 2023 | 2023-10-17 | 576803 | 2023-003 | Significant Deficiency | - | AB |
| 736 | 2023 | 2023-10-17 | 362 | 2023-003 | Significant Deficiency | - | AB |
| 736 | 2023 | 2023-10-17 | 361 | 2023-003 | Significant Deficiency | - | AB |